Dompe Farmaceutici S.P.A Received a Patent for Phenylpropionic Derivatives

Dompe Farmaceutici SpA operates as a holding company in the pharmaceutical industry. The Company provides administration, finance, control, compliance, and human resource management for its operating subsidiaries. Dompe Farmaceutici, through its subsidiaries, conducts medical and genetic research for the global healthcare markets.

Dompe Farmaceutici S.P.A filed patent application numbered 2082/CHENP/2010 that is titled  (R)-4-(HETEROARYL) PHENYLPROPIONIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. This patent application has been granted as Patent Number 299768.

The invention covers Chemical compounds. The present invention relates to a novel class of (R)-4-(heteroaryl) phenylpropionic derivatives of formula (I), useful in the inhibition of chemotactic activation included by the fraction C5a of complement. Said compounds are useful in the treatment of pathologies depending on the chemotactic activation of neutrophils and monocytes induced by the fraction C5a of the complement.

During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act, wherein the examiner stated that the Claim(s) 1-10  are statutorily non-patentable and are mere modifications. 

As a response to said objection, the applicant responded by submitting technical and scientific arguments.

Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.

Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).

Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.